Drug Search Results
More Filters [+]

L-serine

Alternative Names: l-serine
Latest Update: 2024-12-10
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Subcutaneous,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bosnia | Brazil | Croatia | India | Ireland | Taiwan | Thailand | Turkey | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: M.D. Anderson Cancer Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for L-serine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Other

Phase 2: Mesothelioma|Acute Myeloid Leukemia|Pleural Cancer|Non-Small-Cell Lung Cancer|Peripheral Nervous System Diseases|Alzheimer Disease|Carcinoma, Merkel Cell|Hereditary Sensory and Autonomic Neuropathies|Acute Myelomonocytic Leukemia|Acute Erythroblastic Leukemia|Pancreatic Cancer|Myelodysplastic Syndrome|Juvenile Myelomonocytic Leukemia,|Blast Crisis|Preleukemia|Adenocarcinoma|Amyotrophic Lateral Sclerosis|Chronic Myeloid Leukemia|Myelogenous, Chronic, BCR-ABL Positive Leukemia|Acute Megakaryoblastic Leukemia|Acute Monocytic Leukemia|Chronic Myelomonocytic Leukemia|Myeloid, Accelerated Leukemia

Phase 1: Adenocarcinoma|Uterine Cancer|Pancreatic Ductal Carcinoma|Sarcoma|Colorectal Cancer|Cervical Cancer|Melanoma|Pancreatic Cancer|Kidney Cancer|Renal Cell Carcinoma|Graft vs Host Disease|Oncology Solid Tumor Unspecified|Oncology Hematological Unspecified|Stem Cell Transplant

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

RR-DVIVO

P3

Unknown Status

Unknown

2027-12-31

NCI-2024-08121

P1

Not yet recruiting

Uterine Cancer|Adenocarcinoma|Pancreatic Cancer|Cervical Cancer|Kidney Cancer|Renal Cell Carcinoma|Melanoma|Colorectal Cancer|Pancreatic Ductal Carcinoma

2027-10-30

ChiCTR2400089707

N/A

Not yet recruiting

Kidney Diseases

2026-01-01

SENSE

P2

Recruiting

Hereditary Sensory and Autonomic Neuropathies

2025-08-01

Recent News Events